DBV Technologies S.A. — Investor Relations & Filings
Filings indexed
548
across all filing types
Latest filing
2026-05-05
Regulatory Filings
Country
US
United States of America
Listing
US
DBVT
DBV Technologies is a clinical-stage company focused on developing treatments for food allergies. Its core technology is the proprietary Viaskin patch, an investigational platform for epicutaneous immunotherapy (EPIT). This technology is designed to administer allergens to intact skin, aiming to re-educate the immune system and induce tolerance without significant transfer of the antigen into the bloodstream. The company's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergy. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, which has completed early-stage clinical studies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-05 | English | |
| S-8 - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-04 | English | |
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-04-30 | English | |
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-03-26 | English | |
| 8-K - DBV TECHNOLOGIES S.A. (0001613780) (Filer) | 2026-03-02 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41519264 | 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-05 | English | ||
| 41052983 | S-8 - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-04 | English | ||
| 39236607 | 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-04-30 | English | ||
| 33052576 | 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-03-26 | English | ||
| 32895101 | 8-K - DBV TECHNOLOGIES S.A. (0001613780) (Filer) | 2026-03-02 | English | ||
| 30929652 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30929503 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30929703 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30929641 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30929668 | SCHEDULE 13G Filing | 2026-02-03 | English | ||
| 30929693 | 4 Filing | 2026-02-02 | English | ||
| 32895102 | 8-K - DBV TECHNOLOGIES S.A. (0001613780) (Filer) | 2026-01-17 | English | ||
| 12799243 | Major Shareholding Notification 2026 | 2026-01-14 | English | ||
| 12799242 | 4 | 2026-01-14 | English | ||
| 12799244 | Major Shareholding Notification 2026 | 2026-01-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AURORA CANNABIS INC
Global producer and distributor of cannabis for medical and…
|
ACB | US | Manufacturing |
|
AUTOBIO DIAGNOSTICS CO., LTD
Provides IVD solutions for immunoassay, microbiology, and m…
|
603658 | CN | Manufacturing |
|
Autolus Therapeutics plc
Biopharmaceutical company developing programmed T cell ther…
|
AUTL | US | Manufacturing |
|
AVACTA GROUP PLC
Clinical-stage biotech developing targeted oncology drugs w…
|
AVCT | GB | Manufacturing |
|
AVADEL PHARMACEUTICALS PLC
Biopharmaceutical company developing therapies for sleep di…
|
AVDL | US | Manufacturing |
|
Avagenesis Corp.
Develops automated technology for isolating and enriching r…
|
VVA | CA | Manufacturing |
|
Avalon GloboCare Corp.
Develops cell-based immunotherapies and provides precision …
|
ALBT | US | Manufacturing |
|
AVECHO BIOTECHNOLOGY LIMITED
Develops human and animal health products using TPM® drug d…
|
AVE | AU | Manufacturing |
|
Avicanna Inc.
Commercial-stage international biopharma focused on evidenc…
|
AVCN | CA | Manufacturing |
|
Avidity Biosciences, Inc.
Develops a class of RNA therapeutics called Antibody Oligon…
|
RNA | US | Manufacturing |
DBV Technologies S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33512/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33512 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33512 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33512 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33512}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DBV Technologies S.A. (id: 33512)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.